Objectives:~To evaluate the efficacy of Trametinib in reversing metaplasia in participants with Stage 1 gastric cancer~To evaluate the safety of Trametinibin in Stage I gastric cancer patients
This is a study of the safety and effectiveness of Trametinib treatment in patients who have received successful endoscopic submucosal resection of a Stage I gastric cancer.